VERY RSIKY CALL. Low level entry with small risk. The gap has been filled on DTF and price taking support at 200EMA on DTF.
AstraZeneca Pharma India Ltd., a subsidiary of AstraZeneca Plc, UK, is a biopharmaceutical company operating in India. Its core business involves the manufacturing, distribution, and marketing of pharmaceutical products. The company focuses on several therapeutic areas, including oncology, cardiovascular, renal, metabolic, and respiratory diseases. AstraZeneca Pharma India is engaged in commercializing a portfolio of innovative, prescription-based medicines within the Indian healthcare sector. The company also provides clinical trial services to its overseas group entities.
